Boston Scientific (BSX): Set to be a long-term growth leader

For investors employing value, growth, or momentum strategies, the process of identifying high-potential stocks can be simplified with the integration of Zacks Style Scores. This analytical framework stands out as a prominent feature within the Zacks Premium research service.

Based on our quantitative analysis, Boston Scientific (BSX) currently holds a Ranked Stocks (RS) Score of 48.53, placing it in the 3.53rd percentile within its country and sector. A strong point for BSX is its Profitability, scoring 84.22. However, the stock shows weaker performance in Valuation (13.21), Growth (22.13), Momentum (7.56), and EPS Revisions (70.00). Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.